Nipro introduces the SURDIAL™ DX hemodialysis system to the US market, inviting dialysis patients and clinicians to “experience the difference”.

SURDIAL™ DX was developed with key input from clinicians to deliver patient-focused features for optimal performance, efficiency and ergonomics. With its soft launch in late 2021, the US team is proudly rolling out the large-scale commercial version of SURDIAL™ DX to dialysis clinics nationwide.

Fundamental for SURDIAL™ DX:

  • patient safety and comfort
  • ease of use and step-by-step guidance
  • streamlined automated processes
  • ergonomic design
  • supported by continuing clinical education

In addition to machine performance and features, Nipro offers comprehensive services and a comprehensive training certification program to help customers differentiate from current dialysis systems in the United States. Hence Nipro’s invitation to “discover the difference” with SURDIAL™ DX for healthcare professionals and patients, and making it “a true ‘white glove’ experience”, says Renata ZugajDirector of the Medical Instrument Center of North America who led the project.

“SURDIAL™ DX is fully aligned with Nipro’s long-term strategic initiative to be the US provider of complete hemodialysis solutions,” commented Joe Dawson, executive vice president of Nipro Medical Corporation. With local manufacturing in Pennsylvania and backed by a global network of over 60 manufacturing sites, Nipro is indeed well positioned to provide a large-scale renal portfolio to Americans – coupling SURDIAL™ DX with their line of dialyzers, bloodline sets, AVF needles , concentrates, solutions , vascular access management and other renal accessories.

About Nipro Medical Corporation:

Nipro Medical Society – with offices in Bridgewater, New Jersey and Miami, Florida – is a wholly owned subsidiary of Nipro Corporation Japan, headquartered in Osaka. Founded in 1954, Nipro is a global healthcare leader with more than 33,000 employees, 60 manufacturing sites and 240 sales offices across 6 continents.

Nipro’s North America division is responsible for managing the sales, marketing and business operations of United States and Canada – continuously committed to improving patient care and quality of life by developing safe, high-quality, easy-to-use and effective solutions that meet day-to-day clinical goals and reimbursement needs.

SOURCENipro Medical Corporation

Comments are closed.